Perelel has announced a $27 million investment from Prelude Growth Partners including participation from existing investors Unilever Ventures, Willow Growth Partners and Selva Ventures. The company is focused on continuing to provide clinically-proven products to support women throughout their entire hormonal lifecycle.

Perelel is revolutionizing women's health through targeted nutrition. Founded by an OB/GYN, Perelel offers research-backed vitamin routines and simplified daily wellness essentials tailored to key chapters of a woman's hormonal journey-from preconception to perimenopause. Built on a foundation of clinical expertise and uncompromising quality, Perelel is the trusted leader in fertility, pregnancy and postpartum nutrition-while also supporting her stage-specific, whole-body health. Perelel is breaking the one-size-fits-all model that has dominated the category for decades. Perelel was awarded the Clean Label Project Purity Award for most of its products in 2024, given to a select few products out of hundreds.